Rani Therapeutics Holdings, Inc. (RANI) Return On Equity % [USD] 2022 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Rani Therapeutics Holdings, Inc. quarterly/annual Return On Equity history and growth rate from 2022 to 2024.
  • Rani Therapeutics Holdings, Inc. Return On Equity for the quarter ending March 31, 2024 was -108 %, a 164% decline year-over-year.
  • Rani Therapeutics Holdings, Inc. annual Return On Equity for 2023 was -79.9 %, a 142% decline from 2022.
Return On Equity, Quarterly (% [USD])
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 -108 -66.8 -164% Jan 1, 2024 Mar 31, 2024
Q4 2023 -79.9 -46.8 -142% Oct 1, 2023 Dec 31, 2023
Q3 2023 -65.3 -50 -328% Jul 1, 2023 Sep 30, 2023
Q2 2023 -50.9 -41.3 -431% Apr 1, 2023 Jun 30, 2023
Q1 2023 -40.8 -25.9 -174% Jan 1, 2023 Mar 31, 2023
Q4 2022 -33.1 Oct 1, 2022 Dec 31, 2022
Q3 2022 -15.2 Jul 1, 2022 Sep 30, 2022
Q2 2022 -9.59 Apr 1, 2022 Jun 30, 2022
Q1 2022 -14.9 Jan 1, 2022 Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.